Home/Luxa Biotechnology/Eric Oh

EO

Eric Oh

Founder, Co-CEO

Luxa Biotechnology

Therapeutic Areas

Ophthalmology Retinal Diseases

Luxa Biotechnology Pipeline

Drug	Indication	Phase
RPESC-RPE-4W	Dry Age-Related Macular Degeneration (AMD) / Geographic Atrophy	Phase 1/2a

Leadership Team at Luxa Biotechnology

Keith E. Dionne, Ph.D.

Chief Executive Officer

Sally Temple, Ph.D.

Founder, Chief Scientific Officer

Jeffrey Stern, Ph.D., M.D.

Founder, Chief Medical Officer

View full Luxa Biotechnology profile